Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frits W Bär

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Behavioral Medicine|January 22, 2004
Cholesterol changes in coronary patients after a short behavior modification programEllen H Sebregts, Paul R Falger, Frits W Bär, et al.
The American Journal of Cardiology|December 23, 2008
Effect of caldaret on the incidence of severe left ventricular dysfunction in patients with ST-elevation myocardial infarction undergoing primary coronary interventionDan Tzivoni, Jonathan Balkin, Frits W Bär, et al.
Atherosclerosis|September 15, 2005
Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary interventionMartijn Kwaijtaal, Rob van Diest, Frits W Bär, et al.
European Heart Journal|October 13, 2006
Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI studyFrits W Bär, Dan Tzivoni, Maurits T Dirksen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Behavioral Medicine|January 22, 2004
Cholesterol changes in coronary patients after a short behavior modification programEllen H Sebregts, Paul R Falger, Frits W Bär, et al.
The American Journal of Cardiology|December 23, 2008
Effect of caldaret on the incidence of severe left ventricular dysfunction in patients with ST-elevation myocardial infarction undergoing primary coronary interventionDan Tzivoni, Jonathan Balkin, Frits W Bär, et al.
Atherosclerosis|September 15, 2005
Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary interventionMartijn Kwaijtaal, Rob van Diest, Frits W Bär, et al.
European Heart Journal|October 13, 2006
Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI studyFrits W Bär, Dan Tzivoni, Maurits T Dirksen, et al.
Pageof 1